Neurology

Around the Helix: Gene and Cell Therapy Company Updates

Many cell and gene therapy companies are initiating new programs and collaborations with the start of the new year.

Gene Therapy Continues to Show Efficacy in Duchenne Muscular Dystrophy

The placebo crossover cohort experienced statistically significant improvements in NSAA score over external control.

GeneTherapyLive’s Weekly Rewind – January 7, 2022

Review top news and interview highlights from the week ending January 7, 2022.